MIMETICS WITH REVERSE CONFIGURATIONS AND METHODS OF THEIR ADMINISTRATION Russian patent published in 2008 - IPC C07D487/04 A61K31/519 A61K31/53 A61P35/00 

Abstract RU 2342387 C2

FIELD: chemistry; pharmacology.

SUBSTANCE: present invention relates to new compounds with general formula (1), which includes compounds (VI), which relate to conformational stable compounds that imitate the secondary structures of parts of molecules of biologically active peptides and proteins with reverse configurations. The compounds can be used as antitumoral compounds for the treatment and prophylaxis of cancer such as, colorectal cancer, for treating rheumatoid arthritis and ulcerative colitis. The compound facilitates the increase of apoptosis and increases the proliferation of neurites, and inhibits survirin expression in the cell. In compounds, corresponding to the general formula (I) and (VI) , in formula (I) W denotes -Y(C=O)-, -(C=O)NH-, -(SO2)- or is absent, Y denotes an oxygen atom, Z denotes a nitrogen atom or CH, X denotes a nitrogen atom or CH, n=0 or 1, on the condition that when Z denotes CH, X denotes a nitrogen atom and n=1; and when Z denotes a nitrogen atom, then n=0; in formula (VI) X1 denotes a hydroxyl, and at least one of X2 is X3 is a hydroxyl, or X1 denotes hydrogen, and X2 and X3 can be similar of different and independently selected from hydrogen, hydroxyl and halogen. Other radicals have the value specified in the formula of the invention.

EFFECT: obtaining compounds which can be used as antitumoral compounds for the treatment and prophylaxis of cancer such as, colorectal cancer, for treating rheumatoid arthritis and ulcerative colitis.

26 cl, 33 dwg, 9 tbl, 14 ex

Similar patents RU2342387C2

Title Year Author Number
MODULATION OF BETA-CATENIN/TCF-ACTIVATED TRANSCRIPTION 2004
  • Kan Majkl
  • Okh Se Voong
  • Kim Dae Khoon
  • Kha Dzong Riul
  • Khodzhati-Ehmami Katajun
RU2383547C2
BETA-CHAIN MIMETICS AND RELATED METHODS 2003
  • Kan Majkl
  • Masakatsu Eguti
  • Moon Sung-Khvan
  • Chung Dzae-Uk
RU2333213C2
NEW COMPOUNDS MIMETICS AND USING THEM 2008
  • Chung Dzae Uk
  • Dzung Khi-Kiung
  • Dzung Kiung-Jun
  • Dzeong Min-Vook
  • La Khiun-Dzu
  • Li Sang-Khak
  • Kim Khoe-Moon
RU2457210C2
ALPHA-SPIRAL MIMETICS AND METHODS ASSOCIATED WITH THEM 2009
  • Odagami Takenao
  • Kogami Judzi
  • Koudzi Khirojuki
RU2512538C2
NOVEL COMPOUNDS, REPRESENTING REVERSE-TURN MIMETICS, AND THEIR APPLICATION 2008
  • Chung Dzae Uk
  • Dzung Kiung-Jun
  • Dzeong Min-Vook
  • Dzung Khi-Kiung
  • La Khiun-Dzu
RU2470024C2
REVERSE-CONFIGURATION MIMETICS AND METHODS RELATING THERETO 2005
  • Moon Sung Khvan
  • Chung Dzae Uk
  • Li Sung Chan
  • Eguti Masakatsu
  • Kan Majkl
  • Dzeong Kvang Von
  • Ngujen Ku
  • Li Soo Dzin
RU2434017C2
PEPTIDE EPOXY KETONES FOR PROTEASOME INHIBITION 2007
  • Shenk Kevin D.
  • Parlati Franchesko
  • Chzhou Khan'-Tsze
  • Sil'Ven Katrin
  • Smit Mark S.
  • Bennett Mark K.
  • Lehjdig Gaj Dzh.
RU2450016C2
ANTICANCER AGENT 2016
  • Odagami, Takenao
  • Kouji, Hiroyuki
  • Ozawa, Yoichi
  • Hori, Yusaku
RU2729936C2
A CONJUGATE CONTAINING A NEUROTENSIN RECEPTOR LIGAND AND ITS APPLICATION 2015
  • Osterkamp, Frank
  • Haase, Christian
  • Reineke, Ulrich
  • Smerling, Christiane
  • Paschke, Matthias
  • Ungewiss, Jan
RU2743781C2
PTERIDINES EFFECTIVE AS HCV INHIBITORS AND METHODS FOR PRODUCING PTERIDINES 2006
  • Rabuasson P'Er Zhan-Mari Bernar
  • Sjurlero Dominik Lui Nestor Gilehjn
  • Lin' Tse-I
  • Lents Oliver
  • Simmen Kennet Alan
RU2447074C2

RU 2 342 387 C2

Authors

Moon Sung-Khvan

Chung Dzae-Uk

Li Sung-Chan

Eguti Masakatsu

Kan Majkl

Dzeong Kvang-Von

Ngujen Ku

Dates

2008-12-27Published

2004-03-17Filed